Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2024; 14(2): 152-160


Evaluation of the antiatherogenic potential of purple sweet potato (Ipomoea batatas L.) extracts in Wistar rats exposed to a high-cholesterol diet

I Made Jawi, I Wayan Putu Sutirta Yasa, I Gede Widhiantara.




Abstract

Dyslipidemia caused by elevated low-density lipoprotein cholesterol (LDL-C) is one of the causes of atherosclerosis. This study aims to determine the purple sweet potato extract (PSPE) as an antiatherogenic agent in rats fed a high-cholesterol diet. In total, 32 adult male Wistar rats were separated into two groups. A randomized pre-and post-test control design was performed. Before treatment, the lipid profile and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), protein Netrin-1, and apolipoprotein-E (Apo-E) were all evaluated. Group 1, the control group, received a high-cholesterol diet (control), while Group 2 received a high-cholesterol diet supplemented with 200 mg/ml PSPE. Group 2 hereafter will be mentioned as the PSPE group. Both groups were treated by respective treatment for 3 months. At the end of the treatment, the evaluation of necessary parameters was carried out with the pretest. Paired t-test data was obtained. The results showed that the treatment given to Group 2 (high-cholesterol diet supplemented with PSPE) was able to reduce and maintain total cholesterol levels in the posttest by 131.02 ± 4.3 mg/dl when compared to the control group, which was 261.25 ± 18.74 mg/dl in the posttest. There was a significant decrease (p < 0.05) in triglyceride (131.27 ± 1.9 mg/dl), LDL (18.33 ± 4.6 mg/dl), and MDA levels (0.6 ± 0.04 mmol/ml) in the PSPE group compared with the control group in the same parameters. However, there was an increase in the levels of high-density lipoprotein (86.43 ± 1.9 mg/dl), SOD (5.22 ± 0.14 U/ml), Netrin-1 (115 ng/l), and Apo-E (107.52 ng/ml) in the serum of posttest on PSPE group, but not shown in the control group. Following our findings, 200 mg/ml PSPE treatment successfully maintained a lipid profile by reducing oxidative stress and increasing Netrin-1 and Apo-E levels in Wistar rats fed a high-cholesterol diet. These findings indicate that PSPE displays antiatherogenic effects and is possible to be utilized as a new atherosclerosis therapy, whose mechanism of action is described in this study.

Key words: Netrin-1, Apo-E, purple sweet potato, high cholesterol diets, anti-atherogenic






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.